MINT
99 years and younger
All genders
To assess the effect of nintedanib on preserving L-PF measured symptom levels (cough, dyspnea, energy), impacts of disease, and quality of life in patients with MA-ILD who are also receiving SOC treatment. To assess the effect of nintedanib on preserving L-PF measured symptom levels (cough, dyspnea, energy), impacts of disease, …